Healthcare - Medical - Devices - NASDAQ - US
$ 51.3
-5.85 %
$ 7.78 B
Market Cap
24.78
P/E
INCOME STATEMENT
2.96 B
REVENUE
437 M
OPERATING INCOME
427 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Bruker Corporation
| Revenue | 2.96 B |
| Cost Of Revenue | 1.45 B |
| Gross Profit | 1.52 B |
| Operating Expenses | 1.08 B |
| Operating Income | 437 M |
| Other Expenses | 9.7 M |
| Net Income | 427 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | Dec-2009 | Dec-2008 | Dec-2007 | Dec-2006 | Dec-2005 | Dec-2004 | Dec-2003 | Dec-2002 | Dec-2001 | Dec-2000 | Dec-1999 | Dec-1998 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||||||||||||||||
| Revenue | 2 964.5 | 2 530.7 | 2 417.9 | 1 987.5 | 2 072.6 | 1 895.6 | 1 765.9 | 1 611.3 | 1 623.8 | 1 808.9 | 1 839.4 | 1 791.4 | 1 651.7 | 1 304.9 | 1 114.5 | 1 107.1 | 547.6 | 435.8 | 297.6 | 284.4 | 260.7 | 116.4 | 92.7 | 76.6 | 64.7 | 42.2 |
| GROSS PROFIT | ||||||||||||||||||||||||||
| Cost Of Revenue | 1 447.7 | 1 225.0 | 1 208.3 | 1 047.7 | 1 077.3 | 995.6 | 952.9 | 868.8 | 915.2 | 1 045.6 | 1 034.2 | 960.0 | 899.2 | 698.9 | 595.9 | 602.1 | 294.4 | 236.5 | 171.8 | 165.9 | 144.8 | 55.9 | 43.6 | 35.6 | 28.1 | 0 |
| Gross Profit | 1 516.8 | 1 305.7 | 1 209.6 | 939.8 | 995.3 | 900.0 | 813.0 | 742.5 | 708.6 | 763.3 | 805.2 | 831.4 | 752.5 | 606.0 | 518.6 | 505.0 | 253.1 | 199.3 | 125.8 | 118.5 | 115.8 | 60.5 | 49.1 | 41.0 | 36.6 | 42.2 |
| OPERATING INCOME | ||||||||||||||||||||||||||
| Operating Expenses | 1 076.4 | 843.3 | 782.0 | 666.6 | 687.9 | 618.1 | 578.6 | 539.5 | 537.9 | 625.2 | 628.4 | 637.7 | 596.9 | 450.3 | 255.3 | 388.3 | 198.5 | 162.9 | 115.2 | 119.6 | 125.5 | 54.8 | 45.8 | 40.3 | 33.4 | 42.4 |
| Selling, General and Administrative Expenses | 729.4 | 607.4 | 561.2 | 468.6 | 500.2 | 444.7 | 415.9 | 390.5 | 392.2 | 451.0 | 437.9 | 442.4 | 403.6 | 297.3 | 255.3 | 254.5 | 140.0 | 113.0 | 73.8 | 76.4 | 77.8 | 33.8 | 27.7 | 20.2 | 14.8 | 0 |
| Research and Development Expenses | 294.8 | 235.9 | 220.8 | 198.0 | 187.7 | 173.4 | 162.7 | 149.0 | 145.7 | 174.2 | 190.5 | 195.3 | 177.2 | 141.4 | 126.4 | 133.8 | 58.5 | 50.0 | 41.4 | 43.2 | 38.0 | 20.7 | 18.5 | 20.0 | 15.1 | 0 |
| Operating Income | 436.9 | 432.7 | 413.3 | 248.3 | 300.9 | 262.4 | 214.7 | 177.2 | 145.7 | 105.4 | 148.2 | 156.0 | 155.6 | 155.7 | 136.7 | 108.2 | 50.0 | 30.7 | 10.6 | (1.1) | (9.7) | 5.7 | 3.3 | 0.7 | 3.2 | (0.2) |
| PRE-TAX INCOME | ||||||||||||||||||||||||||
| Interest Income Expense | 16.4 | 16.1 | 14.3 | 14.4 | 16.0 | 12.6 | 15.4 | 13.2 | 13.0 | 13.3 | 13.4 | 14.3 | 7.3 | 5.6 | 7.5 | 40.5 | 11.8 | 4.0 | (1.3) | 3.8 | 6.4 | 20.1 | (3.1) | (1.6) | 1.3 | 0 |
| Total Other Income | 107.3 | (18.8) | (19.7) | (22.5) | (20.5) | (17.7) | (21.7) | (4.2) | (17.7) | (4.1) | (23.6) | (17.7) | (10.1) | (5.6) | (7.6) | (15.0) | (89.1) | 3.8 | (0.8) | (3.8) | 1.9 | (9.9) | 2.7 | 1.6 | (1.3) | 0.2 |
| Pre-Tax Income | 544.2 | 413.9 | 393.6 | 225.8 | 280.4 | 244.7 | 197.8 | 177.6 | 128.0 | 101.3 | 124.6 | 138.3 | 145.5 | 150.1 | 129.1 | 93.2 | 48.6 | 34.4 | 11.9 | (4.9) | (7.8) | (4.1) | 6.0 | 2.3 | 1.9 | 0 |
| NET INCOME | ||||||||||||||||||||||||||
| Tax Provision | 117.7 | 116.4 | 113.0 | 64.4 | 82.4 | 63.7 | 117.5 | 23.1 | 23.1 | 41.7 | 42.8 | 60.1 | 51.5 | 53.3 | 48.1 | 28.0 | 16.8 | 15.9 | 8.3 | 2.9 | 9.7 | 2.1 | 2.4 | 0.3 | 1.0 | 0 |
| Net Income | 427.2 | 296.6 | 277.1 | 157.8 | 197.2 | 179.7 | 78.6 | 153.6 | 101.6 | 56.7 | 80.1 | 77.5 | 92.3 | 95.4 | 81.2 | 64.9 | 31.5 | 18.5 | 3.6 | (7.8) | (17.6) | (6.2) | 3.6 | 2.2 | 1.2 | 0 |
| EPS | 2.92 | 2 | 1.83 | 1.03 | 1.27 | 1.15 | 0.5 | 0.95 | 0.6 | 0.34 | 0.48 | 0.47 | 0.56 | 0.58 | 0.5 | 0.4 | 0.61 | 0.18 | 0.1 | 0.0813 | 0.17 | 0.12 | 0.05 | 0.04 | 0.03 | 0 |